首页> 外文期刊>Critical care medicine >The effects of different IV fat emulsions on clinical outcomes in critically ill patients
【24h】

The effects of different IV fat emulsions on clinical outcomes in critically ill patients

机译:不同IV脂肪乳剂对危重患者临床结局的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To examine the effects of different IV fat emulsions on clinical outcomes in critically ill patients. Design: Secondary analysis of data from a prospective multicenter study. Setting: An international sample of ICUs. Patients: Adult patients who were admitted to the ICU for more than 72 hours, were mechanically ventilated within 48 hours, received exclusive parenteral nutrition for more than or equal to 5 days, and did not change IV fat emulsion type during the data collection period. Interventions: Demographic and clinical data were collected for up to 12 days, until death, or discharge from the ICU, whichever came first. Clinical outcomes were recorded at 60 days following ICU admission. Measurements: Lipid-free, soybean, medium-chain triglyceride, olive, and fish oils in parenteral nutrition were compared using an adjusted Cox proportional hazard model to examine time to termination of mechanical ventilation alive, time to ICU discharge alive, and time to hospital discharge alive. Main results: A total of 451 patients were included in this study: 70 (15.5%) in the lipid-free group, 223 (49.5%) in the soybean oil group, 65 (14.4%) in the medium-chain triglyceride group, 74 (16.4%) in the olive oil group, and 19 (4.9%) in the fish oil group. When compared with lipid-free parenteral nutrition, patients who received fish oil had a faster time to ICU discharge alive (hazard ratio, 1.84; 95% CI, 1.01-3.34; p = 0.05). When compared with soybean oil, patients who received olive oil or fish oil had a shorter time to termination of mechanical ventilation alive (hazard ratio, 1.43; 95% CI, 1.06-1.93; p = 0.02 and hazard ratio, 1.67; 95% CI, 1.00-2.81; p = 0.05, respectively) and a shorter time to ICU discharge alive (hazard ratio, 1.76; 95% CI, 1.30-2.39; p < 0.001 and hazard ratio, 2.40; 95% CI, 1.43-4.03; p = 0.001, respectively). Conclusions: Use of alternative IV fat emulsions in parenteral nutrition, particularly olive and fish oil, was associated with improved clinical outcomes.
机译:目的:研究不同IV脂肪乳剂对危重患者临床结局的影响。设计:来自前瞻性多中心研究的数据的二次分析。地点:ICU的国际样本。患者:入院ICU时间超过72小时,在48小时内进行机械通气,接受独家肠胃外营养时间超过或等于5天且在数据收集期间未改变IV脂肪乳剂类型的成年患者。干预措施:收集长达12天的人口统计学和临床​​数据,直至死亡或从ICU出院,以先到者为准。入ICU后60天记录临床结局。测量:使用调整后的Cox比例风险模型比较肠胃外营养中的无脂,大豆,中链甘油三酸酯,橄榄油和鱼油,以检查机械通气终止时间,重症监护病房(ICU)出院时间和住院时间活着放电。主要结果:这项研究共纳入451名患者:无脂治疗组为70(15.5%),大豆油治疗组为223(49.5%),中链甘油三酸酯治疗组为65(14.4%),橄榄油组为74(16.4%),鱼油组为19(4.9%)。与无脂肠胃外营养相比,接受鱼油的患者存活ICU的时间更快(危险比为1.84; 95%CI为1.01-3.34; p = 0.05)。与大豆油相比,接受橄榄油或鱼油的患者活着终止机械通气的时间更短(危险比1.43; 95%CI,1.06-1.93; p = 0.02;危险比1.67; 95%CI ,分别为1.00-2.81; p = 0.05)和更短的ICU存活时间(危险比,1.76; 95%CI,1.30-2.39; p <0.001,危险比,2.40; 95%CI,1.43-4.03; p分别为0.001)。结论:在肠胃外营养中使用替代IV脂肪乳剂,尤其是橄榄油和鱼油,可改善临床效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号